|
By AMANDA PEDERSEN
Medical Device Daily Senior Staff Writer
Being able to differentiate a new medical device is important in any sector, but it's especially crucial when the device is entering a highly competitive space. That is why Cayenne Medical (Scottsdale, Arizona), according to CEO David Springer, worked even harder on designing its recently launched Quattro shoulder system for rotator cuff and labral repair.
"If we didn't show up tomorrow with a shoulder product, shoulders would still be fixed, it's a very competitive market," Springer told Medical Device Daily.
But, he added, many of the company's knee customers also do shoulder procedures — and they do three or four shoulders for every knee repair.
"We are late into the shoulder, there are a lot of folks that already have solutions for the shoulder, but why we came out with it is because we saw a need for a premium quality product that took the best of what's out there and combined it and eliminated some of the negatives," Springer said. "We needed to innovate and have something that was different so doctors would use it." He said one of the questions the company often hears in this space is, "So what? So you've got a shoulder system, so what?"
The Quattro system features a complete line of knotless and pre-loaded PEEK high-strength suture anchors and tailored instrumentation, the company noted. It utilizes Quattro Link Knotless Anchor technology for rotator cuff repairs offering new control in suture management and repair options.
Springer said the Quattro shoulder system also addresses cost-effectiveness concerns because doctors, on average, are using one less anchor per case (four) with the new system, which is what the system is indicated to accept, and the system includes a self-punching version for ease of anchor insertion. "So they're spending less, it takes less time to do the procedure," he said.
One of the biggest challenges in developing the Quattro system, he said, was coming out with a complete system. "There have been competitors who have come out with a single solution," he said. But doctors don't usually want to have to use multiple vendors, so a company with a complete system is likely going to have more success.
Prior to the recent worldwide launch of the Quattro shoulder system, Cayenne did release the device in a limited launch earlier this year. "With medical devices you want to make sure you get it right, so we were very pleased with our limited launch. We had to make very minor and few changes, but that was valuable input and we've had a very successful full launch."
The new shoulder system also features the Quattro X Suture Anchor, preloaded with two strands of #2 Force Fiber high strength suture and developed with a tapered thread design for optimal bone purchase, Cayenne said.
"The Quattro shoulder system enables a truly comprehensive, cost-effective and intuitive approach to shoulder repair," said Kenneth Montgomery, MD, of Tri-County Orthopaedic & Sports Medicine (Morristown, New Jersey) said. "The ability to manually set tension and reverse tension, if needed, enables an anatomic repair through a simplified procedure. The new Link Anchor easily accepts multiple suture strands, which I have found especially useful in cases with complex tears or limited bone for anchor implantation."
For labral repair, the system includes the pre-loaded Quattro GL Suture Anchor, featuring an eyelet design for simplified suture management. All anchor options provide high pull-out strength (419N with the GL Suture Anchor, 447N with the X Suture Anchor, and 519N with the Link Knotless Anchor) for a secure, reliable repair, and are available in a variety of sizes to accommodate individual patient pathology.
In addition to suture anchors, the system includes the Quattro Suture Passer and tailored instrumentation for anchor implantation, the company noted.
Cayenne is a private, venture-backed sports medicine company. Earlier this year it raised a $10 million equity financing with new investor Fletcher Spaght Ventures joining existing investors Split Rock Partners, MB Venture Partners and Investor Growth Capital (Medical Device Daily, Feb. 15, 2012).
Published July 20, 2012
|
